Results 271 to 280 of about 79,213 (303)
Some of the next articles are maybe not open access.
Infigratinib for cholangiocarcinoma
Drugs of Today, 2022Cholangiocarcinoma (CCA) is a serious and often fatal cancer of the bile ducts of the liver with a 5-year survival rate of 5-15%. At the time of diagnosis, most patients present with advanced or metastatic CCA, which is an aggressive malignancy with a poor prognosis.
openaire +2 more sources
Surgical Pathology Clinics, 2018
This article focuses on cholangiocarcinoma, both intrahepatic and extrahepatic. The various classification schemes based on anatomic location, macroscopic growth pattern, microscopic features, and cell of origin are outlined. The clinicopathologic, immunohistochemical and molecular differences between intrahepatic cholangiocarcinoma and extrahepatic ...
openaire +2 more sources
This article focuses on cholangiocarcinoma, both intrahepatic and extrahepatic. The various classification schemes based on anatomic location, macroscopic growth pattern, microscopic features, and cell of origin are outlined. The clinicopathologic, immunohistochemical and molecular differences between intrahepatic cholangiocarcinoma and extrahepatic ...
openaire +2 more sources
Surgical Clinics of North America, 2014
Cholangiocarcinoma involving the distal common bile duct (distal cholangiocarcinoma [DCC]) is a periampullary neoplasm that is less common than, but often difficult to distinguish from, pancreatic adenocarcinoma (PDA). The prognosis and cure rate of DCC is improved over that of PDA, but it remains a highly lethal disease.
Paxton V, Dickson, Stephen W, Behrman
openaire +4 more sources
Cholangiocarcinoma involving the distal common bile duct (distal cholangiocarcinoma [DCC]) is a periampullary neoplasm that is less common than, but often difficult to distinguish from, pancreatic adenocarcinoma (PDA). The prognosis and cure rate of DCC is improved over that of PDA, but it remains a highly lethal disease.
Paxton V, Dickson, Stephen W, Behrman
openaire +4 more sources
Epidemiology of cholangiocarcinoma
Best Practice & Research Clinical Gastroenterology, 2015Cholangiocarcinoma (CCA) is a cancer arising from the intra- or extrahepatic bile ducts and mainly characterized by its late diagnosis and fatal outcome. CCA is the second most common primary liver tumour and accounts for approximately 10-15% of all hepatobiliary malignancies.
Annika, Bergquist, Erik, von Seth
openaire +2 more sources
Transplantation for Cholangiocarcinoma
Clinics in Liver Disease, 2011Cholangiocarcinoma (CCA) is a primary hepatic neoplasm that arises from malignant transformation of the biliary epithelium. Chronic biliary tree inflammation as occurs in primary sclerosing cholangitis (PSC) is a risk factor for the development of CCA.
Howard C, Masuoka, Charles B, Rosen
openaire +2 more sources
Journal of Magnetic Resonance Imaging, 2014
Cholangiocarcinomas are the second most common primary hepatobiliary tumors after hepatocellular carcinomas. They can be categorized either based on their location (intrahepatic/perihilar/extrahepatic distal) or their growth characteristics (mass‐forming/periductal‐infiltrating/intraductal) because they exhibit varied presentations and outcomes based ...
Kartik S, Jhaveri, Hooman, Hosseini-Nik
openaire +2 more sources
Cholangiocarcinomas are the second most common primary hepatobiliary tumors after hepatocellular carcinomas. They can be categorized either based on their location (intrahepatic/perihilar/extrahepatic distal) or their growth characteristics (mass‐forming/periductal‐infiltrating/intraductal) because they exhibit varied presentations and outcomes based ...
Kartik S, Jhaveri, Hooman, Hosseini-Nik
openaire +2 more sources
The Epidemiology of Cholangiocarcinoma
Seminars in Liver Disease, 2004The incidence rates of cholangiocarcinoma (CC) vary greatly among different areas of the world, and this variation is related to distribution of risk factors. Intrahepatic cholangiocarcinoma (ICC) and extrahepatic cholangiocarcinoma (ECC) have different epidemiological features.
Yasser, Shaib, Hashem B, El-Serag
openaire +2 more sources
Surgical Oncology Clinics of North America, 2014
Optimal treatment of hilar cholangiocarcinoma depends on location of the cancer and extent of biliary and vascular involvement. Candidates for resection or transplantation must be evaluated and managed by a multidisciplinary team at a high-volume hepatobiliary center.
Victor M, Zaydfudim +2 more
openaire +2 more sources
Optimal treatment of hilar cholangiocarcinoma depends on location of the cancer and extent of biliary and vascular involvement. Candidates for resection or transplantation must be evaluated and managed by a multidisciplinary team at a high-volume hepatobiliary center.
Victor M, Zaydfudim +2 more
openaire +2 more sources
Intrahepatic Cholangiocarcinoma
Techniques in Vascular and Interventional Radiology, 2015Cholangiocarcinoma is a rare malignancy that arises from epithelial cells of the biliary system. Its desmoplastic histology and the heterogeneity of its presentation have contributed to its poor prognosis, with limited therapeutic options previously available.
openaire +2 more sources